Hantz Financial Services’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Buy
828
+107
+15% +$1.87K ﹤0.01% 2052
2026
Q1
$14K Sell
721
-14
-2% -$304 ﹤0.01% 1974
2025
Q4
$16K Buy
735
+697
+1,834% +$12.6K ﹤0.01% 1867
2025
Q3
$0 Sell
38
-2
-5% -$27 ﹤0.01% 2446
2025
Q2
$1K Buy
40
+5
+14% +$99 ﹤0.01% 2138
2025
Q1
$1K Buy
+35
New +$1.02K ﹤0.01% 1615

Other funds holding TNDM

Hantz Financial Services's TNDM Position: Q2 2026 in Review

Hantz Financial Services increased its Tandem Diabetes Care (TNDM) stake by 15% in Q2 2026, buying an estimated $1.87K and bringing the position to 828 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2052.

Hantz Financial Services first reported a position in TNDM in Q1 2025 and has held it in 6 quarters since. The position peaked at $16K in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Hantz Financial Services held 828 shares of Tandem Diabetes Care worth $12K as of Q2 2026.
  • Hantz Financial Services bought 107 Tandem Diabetes Care shares in Q2 2026, an estimated $1.87K.
  • Tandem Diabetes Care made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2052 holding.
  • Hantz Financial Services first reported a position in Tandem Diabetes Care in Q1 2025 and has held it in 6 quarters since.
  • Hantz Financial Services's Tandem Diabetes Care position peaked at $16K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.